Duncan helps clients develop and implement their intellectual property strategy with a focus on patents and registered designs.
Duncan specialises in all aspects of patents, registered designs and copyright and their commericalisation. He has a deep understanding of the aeronautical, building, cleantech, greentech, infrastructure, manufacturing, marine, medical devices, mining and mineral, packaging, recreational, sustainability, and transport fields.
Prior to working at Baldwins (now AJ Park), Duncan worked as an intellectual property (IP) specialist both in leading IP firms and as in-house IP counsel. This combination of experience since 2000 brings a unique perspective and understanding of clients’ needs. Before that, he worked as an R&D thermal and mechanical design engineer for a multinational power electronics company.
Duncan enjoys understanding clients’ needs and their business goals and aligning their IP strategy and rights to match these goals. He also enjoys working closely with his clients to understand their invention, how it works, its application and future applications it might have.
Duncan is based in our Auckland office and regularly travels to Christchurch and the surrounding areas to work with clients.
- BE (Eng Sc), University of Auckland (1994)
- ME (Mech), University of Auckland (1997)
- LLB, University of Auckland (2009)
- Admitted as a Barrister & Solicitor of the High Court of New Zealand
- Registered Patent Attorney (New Zealand and Australia)
Duncan Schaut 's insights
\ 3 Aug 2021
AJ Park’s continued recognition for excellence and expertise
We’re pleased to be named amongst the very best in the most recent rankings for Best Lawyers, IAM Patent 1000, Managing IP…
Article \ 18 Jun 2021
Australian innovation patent system approaches the finish line
The Australian innovation patent system is being phased out, with key changes taking place on 25 August 2021 (AEST). Steps must be…
Article \ 29 Apr 2021
Managing intangible assets for exponential growth
Intangible assets do not occupy physical space. However, they have the potential to provide high value and exponential growth when identified and…
Article \ 3 Dec 2020
Australian High Court rejects the implied licence doctrine: establishes exhaustion…
The High Court of Australia has recently passed down a landmark 4-3 majority decision in Calidad Pty Ltd v Seiko Epson Corporation…
Article \ 30 Nov 2020
Medicinal cannabis in New Zealand – a potted summary of…
The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 came into effect from 1 April 2020. These regulations establish a scheme for licencing…
Article \ 26 Nov 2020
Pesky pandemics and patents: how the conventional patent approach appears…
Over 70 vaccines and 150 drugs are currently being developed by various entities in an effort to combat the COVID-19 pandemic. Any…
Article \ 18 Nov 2020
Proposed changes to New Zealand intellectual property laws
The New Zealand Government has recently proposed several amendments to New Zealand’s intellectual property laws, including the Patents Act 2013 (PA), the…